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Shroom, a PDZ Domain±Containing
Actin-Binding Protein, Is Required
for Neural Tube Morphogenesis in Mice
as exencephaly, acrania, and craniofacial clefting, while
caudal NTDs can result in spina bifida.
A number of intrinsic and extrinsic genetic, molecular,
and environmental factors that regulate neural tube mor-
phogenesis in mice have been identified. For example,
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targeted mutations in the genes for twist and cart1 dem-Seattle, Washington 98109-1024
onstrate a critical role for the surrounding head mesen-
chyme in neurulation (Chen and Behringer, 1995; Zhao
et al., 1996). In contrast, NTDs caused by targeted muta-Summary
tions in the jnk, p300, ski, and hes1 genes are due to
intrinsic defects in the proliferation, survival, and differ-Using gene trap mutagenesis, we have identified a
entiation of neuroepithelial cells (Ishibashi et al., 1995;
mutation in mice that causes exencephaly, acrania,
Berk et al., 1997; Yao et al., 1998; Kuan et al., 1999).
facial clefting, and spina bifida, all of which can be
While these examples provide insights into some of
attributed to failed neural tube closure. This mutation
the factors that determine neurulation, they provide lim-
is designated shroom (shrm) because the neural folds
ited information regarding the identity and regulation
ªmushroomº outward and do not converge at the dor- of the intrinsic structural molecules that facilitate the
sal midline. shrm encodes a PDZ domain protein that conversion of the neural plate into the neural tube. This
is involved at several levels in regulating aspects of extensive remodeling necessitates coordinated changes
cytoarchitecture. First, endogenous Shrm localizes to in cell shape, adhesion, and migration, and both phar-
adherens junctions and the cytoskeleton. Second, ec- macological and genetic approaches have uncovered a
topically expressed Shrm alters the subcellular distri- clear role for the cytoskeleton in this process. For exam-
bution of F-actin. Third, Shrm directly binds F-actin. ple, treatment of embryos with cytoskeletal disrupting
Finally, cytoskeletal polarity within the neuroepithe- agents blocks neural tube closure (Karfunkel, 1971;
lium is perturbed in mutant embryos. In concert, these Ybot-Gonzalez and Copp, 1999). In support of these
observations suggest that Shrm is a critical determi- pharmacological results, vinculin (Xu et al., 1998a),
nant of the cellular architecture required for proper Marcks (Stumpo et al., 1995), MacMarcks (Chen et al.,
neurulation. 1996; Wu et al., 1996), Mena/profilin I (Lanier et al., 1999),
and Arg/Abl (Koleske et al., 1998), all of which are either
cytoskeletal proteins or putative regulators of cytoskele-
Introduction tal dynamics, have been linked to neurulation via the
generation of knockout mice. While it remains to be
Neural tube closure is accomplished by a complex mor- precisely determined how these mutations and treat-
phogenetic program requiring precisely choreographed ments elicit such phenotypes, defects in DLHP forma-
cellular proliferation, differentiation, adhesion, and mi- tion and neural fold convergence are found in each case.
gration (Schoenwolf and Smith, 1990). The sensitivity of During neurulation cells regulate adhesion between
neurulation to even slight alterations in this develop- neighboring cells and the underlying basement mem-
mental program probably accounts for the observation brane through the use of specialized cell±cell and cell±
that neural tube defects (NTDs) affect nearly one in every extracellular matrix (ECM) adhesion structures. Typically,
thousand human births (Copp et al., 1990; Golden and these interactions are mediated by transmembrane re-
Chernoff, 1995). Neurulation proceeds in a series of ceptors that bind ligand on the outside of the cell and
steps by which the neural plate is shaped, elongated, are indirectly linked to actin filaments by intricate protein
and bent to form a tube that extends the entire length complexes on the inside of the cell (Gumbiner and
of the anterior±posterior (AP) axis. To form the neural McCrea, 1993; Burridge and Chrzanowska-Wodnicka,
1996). In addition, these complexes also initiate signalstube, the neural plate undergoes a bending process by
that regulate gene expression, cell proliferation, and dif-which the lateral edges, or neural folds, elevate, rotate
ferentiation (Gumbiner, 1996; Parsons, 1996). Perhapsaround the actin-rich dorsal±lateral hinge points (DLHPs),
the best-characterized cell±cell adhesion structure isand converge at the dorsal midline (Smith and Schoen-
the adherens junction (AJ). In these structures, receptorswolf, 1997). Following convergence, the edges fuse to
of the cadherin superfamily mediate homotypic intercel-form a seamless tube. In the cranial region, closure is
lular interactions with their large extracellular domains,initiated at defined fusion points located at the anteri-
while their cytoplasmic tails are linked to the actin cy-ormost point of the forebrain, the forebrain/midbrain
toskeleton via catenins, a-actinin, and vinculin (Menkelboundary, and the hindbrain/spinal chord boundary (Sa-
et al., 1994; Rimm et al., 1995; Weiss et al., 1998). Thiskai, 1989). Following fusion, closure along the remainder
interaction with F-actin nucleates the formation of aof the neural tube proceeds in a zipper-like fashion in
dense, submembranous actin belt that serves to linkdefined directions. Rostral NTDs are typically manifest
adjacent cells and regulate cell shape, migration, and
polarity (Gumbiner, 1996). Unfortunately, the exact role
of AJs in neurulation has not been established because* To whom correspondence should be addressed (e-mail: psoriano@
fhcrc.org). the molecules that form these structures are required
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Figure 1. Phenotype of shrm Mutant Em-
bryos
(A±D) shrm mutant embryos isolated at E9.5
(A), E10.25 (B and C), and E14.5 (D). (A) Lateral
view of a wild-type and mutant E9.5 embryo.
(B and C) Lateral views of E10.25 wild-type
and shrm mutant embryos. Lines in (B) denote
the positions of the transverse sections in (E)
and (F), while the arrowhead in (C) denotes
spina bifida. (D) Lateral view of E14.5 wild-
type and mutant embryos with herniation of
the liver (li) and intestines (in).
(E and F) Transverse, H&E-stained sections
of E10.25 wild-type (E) and shrm mutant (F)
embryos. Note the abnormal morphology of
the neural tube (nt) and that the forebrain (fb)
neuroepithelium (ne) is not fused.
(G±J) Scanning electron microscopy of
E10.25 wild-type (G and I) and shrm mutant
(H and J) embryos. (G and H) Lateral views
of the head. Magnification is 553. (I and J)
Fixed embryos were cut transversely just an-
terior to the forelimb, mounted on the dorsal
side, and viewed. Magnification is 1803. ov,
otic vesicle; 11, wild type; - -, homozygote.
Bars, 200 mm (A); 250 mm (B and C); 300 mm
(D); 100 mm (E±J); 40 mm (I±J).
at earlier stages of development (Larue et al., 1994; Results
Haegel et al., 1995; Torres et al., 1997). While cadherins
and catenins are necessary for many normal develop- Characterization of the shroom Mutation
As part of an ongoing analysis of developmental genemental processes, disruption of AJs also correlates with
the oncogenic and metastatic potential of some tumors trap mutants, we identified a recessive, lethal gene trap
mutation, ROSA-53, that causes extensive NTDs. In light(Breen et al., 1993; Oyama et al., 1994; Kawanishi et al.,
1995). of the observation that the neural folds ªmushroomº
away from the dorsal midline, this mutation has beenThis report describes the identification and character-
ization of shroom (shrm), a mouse mutation that causes designated shroom (shrm).
To characterize the shrm phenotype, mutant embryosexencephaly, acrania, facial clefting, spina bifida, and
herniation of internal organs. The shrm gene is ex- from embryonic day (E) 8.25 to E17.5 were isolated and
analyzed. Most shrm embryos are viable at all embryonicpressed in the neuroepithelium, the ventrolateral body
wall, and the gut, suggesting these phenotypes result stages, indicating that shrm mutants survive to term but
probably died during or very shortly after birth. Mutantdirectly from a loss of Shrm protein. shrm encodes a
PDZ domain±containing cytoskeletal protein that can embryos can be distinguished phenotypically by E9.25,
as the lateral edges of the cranial neural folds are wavydirectly bind F-actin and regulate its subcellular distribu-
tion in cells. In addition, we show that cytoskeletal polar- in appearance and have not converged at the dorsal
midline (Figure 1A). By E10.25 the phenotype is manifestity is perturbed in Shrm-deficient neuroepithelium. Taken
together, these results suggest a cytoskeletal basis for as an open neural tube that extends rostrally from the
otic vesicle (Figures 1B±1D and 1H). Occasionally, de-the severe NTDs observed in shrm mutant embryos.
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fects in caudal neural tube closure occur, resulting in and forebrain (Figure 2D). The expression pattern deter-
mined by X-gal staining has been confirmed by whole-spina bifida (Figure 1C, arrowhead). Histological analy-
mount RNA in situ hybridization using a probe to thesis and scanning electron microscopy of transverse sec-
trapped gene (data not shown).tions through E10.25 shrm mutant embryos show that
the neural tube is malformed along the entire AP axis
shrm Embryos Are Patterned Correctlyand the forebrain neuroepithelium is exposed (Figures
There are several possible mechanisms that could ex-1F and 1J). Specifically, the neural tube is foliated, and
plain the NTDs observed in shrm mutant embryos, in-the roof plate is abnormal. Other midline structures and
cluding abnormalities in patterning that act autono-surrounding tissues, such as the notochord, floor plate,
mously within the neuroepithelium. The expression ofhead mesenchyme, and somites, appear normal in shrm
shrm in the cranial neuroepithelium, but not in the headmutant embryos. By E14.5, failed neural tube closure
mesenchyme, makes this a particularly realistic model.results in exencephaly, acrania, and facial clefting (Fig-
Conversely, based on the expression of shrm in theure 1D). Some shrm mutants also display defects in
paraxial mesoderm and the previous report that meso-ventral closure, resulting in herniation of the intestine
derm can play a role in patterning the neural tubeand liver (Figure 1D).
(Grapin-Botton et al., 1998), it is possible that the caudalNot all of the observed phenotypes are fully penetrant.
NTDs observed in shrm mutant embryos are secondaryWhile all homozygous mutant embryos exhibited exen-
to a defect in paraxial mesoderm. To test these models,cephaly, 87% (68/78) of the E11.5±E17.5 mutant em-
wild-type and shrm mutant embryos were assayed bybryos exhibited definitive craniofacial clefting, and 23%
whole-mount RNA in situ hybridization or immunostain-(21/93) of the E10.5±E17.5 mutant embryos displayed
ing to detect alterations in patterning. Probes to wnt3Aspina bifida. A small number, 8% (21/279), of heterozy-
(Figures 3A and 3B), wnt1, krox20, and sonic hedgehoggous embryos displayed a much less severe form of
(data not shown) were used to assess patterning of theexencephaly (data not shown). Finally, only 12% (7/59)
neural tube and axial mesoderm; probes for twist (Figureof the E13.5±E17.5 mutant embryos displayed clear de-
3C), PDGFa receptor (Figure 3D), and Mox1 protein (Fig-fects in ventral closure. Because only a small percentage
ure 3E) were used to evaluate paraxial mesoderm andof shrm mutant embryos exhibit ventral closure defects,
head mesenchyme; and an antibody to neurofilamentthe remaining analysis focuses on the fully penetrant
was used to test for neuronal neural crest derivativesneural tube defect.
(Figure 3F). The only notable difference is in the expres-
sion domain of wnt3A, which is slightly expanded and
diffuse at the dorsal midline of mutant embryos (FigureExpression of shrm
3B). However, this expression pattern may be secondaryThe gene trap vector used to generate the shrm mutation
to the abnormal roof plate and undulated nature of thecontains a b-galactosidase reporter gene that should
neural tube. In addition, it is well documented that alter-be expressed under the control of the trapped gene's
ations in cranial neural crest cells can cause NTDs. Toendogenous promoter. Therefore, heterozygous shrm
determine whether the shrm phenotype results from aembryos were isolated and stained with X-gal to deter-
neural crest defect, we assayed the integrity of the cra-mine the temporal and spatial expression of the reporter.
nial skeleton, as many of these structures are derivedAt E8.75, prior to the onset of the phenotype, intense
from neural crest cells (reviewed in Le Douarin et al.,staining is detected in the rostral portion of the embryo
1993). In mutant embryos, the bones comprising thein the cranial neuroepithelium (Figures 2A and 2E). In
cranial vault do not form, and while the bones thatthe trunk region at this stage, staining is seen in the
make up the base of the skull are present, they tend toneural tube, the paraxial mesoderm, and the gut (Figures
be slightly smaller and less well developed (data not2A, 2E±2G). The robust expression of shrm in the neuro-
shown). It is likely that these defects are secondary to
epithelium rostral to the otic vesicle, but not in the sur-
the exencephalic development of the brain.
rounding head mesenchyme, correlates well with the
NTDs can also result from an imbalance between cell
temporal and spatial onset of the fully penetrant pheno- proliferation and cell survival in the neural tube, paraxial
types and strongly supports the hypothesis that Shrm mesoderm, and/or head mesenchyme. Therefore, wild-
acts autonomously within the neuroepithelium. At E10.5, type and mutant E9.75 embryos were assayed to deter-
expression in the rostral portion of the embryo is local- mine the relative amounts of apoptosis (data not shown)
ized to the neural tube and forebrain (Figures 2B and and cell proliferation (Figures 3G±3I). These assays re-
2H). In the trunk region, shrm expression is detected in veal no significant differences between wild-type and
the neural tube, somites, ventral body wall, heart, and shrm mutant embryos, suggesting the phenotype is not
gut (Figures 2B, 2H±2J). Interestingly, shrm expression related to aberrant cell proliferation or cell survival. Simi-
in the neural tube is quite dynamic, suggesting that only larly, by counting the nuclei in each of the tissues as-
certain cells or processes require Shrm function during sayed, it appears that the total number on cells compris-
neurulation. Specifically, shrm expression is limited to ing these compartments is unchanged in shrm mutant
the floor and roof plates as development progresses embryos. In addition, histological analysis also sug-
but appears more widespread during the formation of gested there were no overt abnormalities in the tissues
the neural tube (Figure 2H). The strong expression of that surround and support the neuroepithelium (Figure
shrm in the ventral body wall and gut is consistent with 1, data not shown). In order to more carefully evaluate
the ventral closure defects exhibited by some mutant the formation of these tissues, wild-type and shrm mu-
embryos. By E14.5 of development, shrm expression is tant embryos were viewed at high resolution using scan-
ning electron microscopy (Figures 1I, 1J, 3J, and 3K).restricted to the skeletal muscle, distal tips of the digits,
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Figure 2. Embryonic Expression of the Gene
Trap Reporter
(A±D) Heterozygous embryos were isolated
and assayed by whole-mount X-gal staining
to determine the temporal and spatial expres-
sion of the b-gal gene trap reporter at E8.5
(A), E10.5 (B), E12.5 (C), and E14.5 (D) of de-
velopment.
(E±J) Sections of X-gal-stained shrm hetero-
zygous embryos. Transverse (E and G) and
sagital (F) sections of E8.5 stained embryos
reveal expression in the cranial neuroepithe-
lium (ne), neural tube (nt), optic pits (op), fore-
gut (fg), hindgut (hg), somites (s), and preso-
mitic mesoderm (sm). Note the high level of
expression in the cranial neural folds but the
absence of expression in the head mesen-
chyme at this stage. (H±J) Transverse sec-
tions through an X-gal-stained E10.5 hetero-
zygous embryo reveal expression in the
neural tube (nt), roofplate (rp), floorplate (fp),
somitic mesoderm (sm), heart (h), ventral
body wall (bw), and midgut (mg). ba, branchial
arch; fl, forelimb bud; hl, hindlimb bud. Bars,
100 mm (A); 150 mm (B); 200 mm (C); 300 mm
(D); 100 mm (E±J).
Despite the fact that the neural tube is severely mal- two different putative protein products (Figures 4A and
4B). The longest predicted transcript, shrmL, encodes aformed, imaging at this resolution reveals no differences
in the size, shape, or architecture of the tissues sur- protein of 1986 amino acids, while the second transcript,
shrmS, encodes a protein of 1808 amino acids that lacksrounding the neural tube.
In concert, these data suggest there are no alterations the N-terminal 177 amino acids of ShrmL. Based on the
observation that the 59RACE product was identical toin patterning, proliferation, or cell survival affecting ei-
ther the neuroepithelium, head mesenchyme, or paraxial the 59 UTR of the shrmS transcript, we predict the gene
trap insertion occurred 39 of the translational start sitemesoderm that could account for the observed NTDs.
In light of this information, it is possible the NTDs are for ShrmL, but 59 of the translational start site for ShrmS
(Figure 4A). Therefore, the observed X-gal staining maycaused by a structural or mechanical defect that acts
autonomously within the cells comprising the neural represent the expression of shrmS. However, RNA in
situ hybridization indicates that most cells may normallytube. This is supported by the observation that shrm is
exclusively expressed in the cranial neural folds, but not express both ShrmS and ShrmL (data not shown).
Analysis of the protein sequence indicates that shrmin the surrounding head mesenchyme, and this tissue
is affected in 100% of the mutant embryos observed. belongs to a gene family consisting of shrm, apx, and
APXL (Figures 4B±4E). Apx, which appears to be a com-Furthermore, as shrm is expressed in the caudal neuro-
epithelium, the mechanism that causes the cranial de- ponent or regulator of amilioride-sensitive sodium chan-
nels, was identified by expression cloning using an anti-fects may also cause the caudal defects.
body that recognized the apical surface of Xenopus
epithelial cells (Staub et al., 1992). APXL is a humanshrm Encodes a Novel PDZ Domain Protein
The cDNA for the trapped gene was cloned using gene named for its similarity to apx (Schiaffino et al.,
1995). Shrm is 35% and 28% identical to APXL and Apx59-RACE and library screening. Sequence analysis indi-
cates there are at least two shrm transcripts that encode over the entire length of the protein. ShrmL and APXL
The Actin-Binding Protein Shrm in Neurulation
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Figure 3. Patterning and Proliferation of
shrm Mutant Embryos
Wild-type and shrm mutant embryos were
isolated and assayed by whole-mount RNA
in situ hybridization (A±D), whole-mount im-
munohistochemistry (E and F), BrdU incorpo-
ration (G±I), or scanning electron microscopy
(J and K).
(A and B) Detection of wnt3a at E9.75 ([A],
lateral view) or E11.5 ([B], dorsal view).
(C) Lateral view of E10.5 wild-type and shrm
mutant embryos stained to detect twist.
(D) Lateral view of E10.5 wild-type and shrm
mutant embryos stained to detect PDGFa re-
ceptor.
(E) Lateral view of E9.25 wild-type and shrm
mutant embryos stained to detect Mox1.
(F) Lateral view of E10.5 wild-type and shrm
mutant embryos stained to detect neurofil-
ament.
(G and H) Transverse sections of BrdU-
labeled wild-type (G) and mutant (H) E9.75
embryos. Brown nuclei are BrdU-positive
cells and indicate active cell proliferation.
Sections were counterstained with hematox-
ylin to detect all nuclei.
(I) Mitotic index in various tissues from wild-
type and shrm mutant E9.75 embryos. The
mitotic index was calculated by dividing the
number of BrdU-positive nuclei by the total
number of nuclei in each tissue. Data were
determined by counting five adjacent sec-
tions from two different embryos of each ge-
notype indicated.
(J and K) Lateral view scanning electron mi-
crographs of the somites at the level of the
hindlimb in E10.25 wild-type (J) and mutant
(K) embryos. Magnification, 1503. Bar, 100
mm.
are 45% identical over the N-terminal 268 amino acids. immunoprecipitation and Western blot analysis (Figure
5A). In these experiments, anti-ShrmC antibodies, butWithin these sequences of Shrm and APXL are single
PSD-95/Dgl/ZO-1 (PDZ) domains that are 64% identical. not preimmune antibodies, detect proteins of the pre-
The PDZ domains of ShrmL and APXL are most similar dicted molecular weights for ShrmS and ShrmL in wild-
to those found in the Enigma and Ril type Lim domain type embryo lysates (lane 1 versus lane 3). Importantly,
proteins (Figure 4C; Kuroda et al., 1996). Apx, APXL, expression of these proteins is not detected in shrm
and Shrm all contain centrally and C-terminally located mutant embryos (lane 2). Similar results were obtained
domains that are well conserved (Figures 4D and 4E). using antibodies to the PDZ domain and Northern blot
These domains, ASD1 and ASD2 (Apx/Shrm domain), analysis using nucleotides 632±2534 as a probe detects
share no homology with other known proteins and have no shrm mRNA in mutant embryos (data not shown).
no identified function. Shrm and APXL are 52% and 60% Thus, we predict this mutation causes a null allele for
identical in ASD1 and ASD2, respectively, while Shrm shrmL and shrmS.
and Apx are 35% and 45% identical in ASD1 and ASD2. In an effort to understand the cell biological role of
Finally, Shrm contains two peptide motifs that might be shrm, we employed indirect immunofluorescence to an-
important for its function: (1) a putative PDZ domain± alyze the subcellular distribution of endogenous Shrm
binding site at its C terminus consisting of the sequence protein in both primary cells derived from wild-type neu-
Ser-Pro-Leu (Figure 4E; Songyang et al., 1997) and (2) ral tubes (Figure 5B) and neuroepithelial cells cultured
a consensus binding site for EVH1 domains starting in the presence of FGF-2 (Kilpatrick and Bartlett, 1993;
at amino acid 1533 and consisting of the sequence data not shown). In both populations of cells, Shrm local-
DFPPPPP (Gertler et al., 1996; Niebuhr et al., 1997). izes to structures that resemble AJs (arrows) and actin
stress fibers (arrowheads). To verify these observations,
primary neural tube cells were costained to detect Shrmshrm Protein Expression and Subcellular Localization
(Figures 5C, 5E, and 5G) and either vinculin (Figure 5D),To biochemically characterize Shrm protein and verify
b-catenin (Figure 5F), or F-actin (Figure 5H). These ex-that the trapped allele was protein null, polyclonal anti-
bodies to the C terminus were generated and used for periments reveal colocalization of Shrm with vinculin
Cell
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Figure 4. Cloning of shrm
(A) Schematic representation of the 59 ends of shrmL and shrmS transcripts. cDNAs encoding the remainder of the protein are not depicted.
SA, splice acceptor; reporter, bgalCre; underlined portion encodes the PDZ domain; dark gray region, shrmS-specific exon of 59 UTR; hatched
and black regions, exons common to shrmL and shrmS transcripts; light gray regions, shrmL-specific sequences for the 59UTR and PDZ
domain.
(B) Schematic of ShrmL and ShrmS in relation to the predicted structures of APXL and Apx. Vertical arrow, site of the gene trap insertion;
black oval, PDZ domain; hatched oval, ASD1; striped oval, ASD2; diamond, putative EVH1-binding site; light gray oval, PDZ domain±binding
site.
(C) Sequence alignment of the PDZ domains from Shrm, APXL, and Enigma.
(D and E) Sequence alignments of ASD1 and ASD2, respectively. Identical or conserved amino acids are boxed in dark gray or light gray,
respectively. Underlined amino acids in (E) constitute the putative PDZ domain±binding site.
and b-catenin in AJs. Note that Shrm does not colocalize and 1474±1986, indicating that the PDZ and ASD2 do-
mains are not required for this activity (data not shown).with vinculin in focal adhesions, sites of cell±ECM con-
tact (Figure 5D, double arrowhead). This analysis also To determine whether the observed actin structures
were caused by the ability of Shrm to recruit actin toshows that Shrm colocalizes with F-actin in both stress
fibers and AJs. Similar analysis of cells derived from ectopic sites, a fusion protein between amino acids
1±1264 of Shrm and the membrane-anchoring sequencemutant embryos reveals no Shrm staining in AJs or
stress fibers. However, these cells possess vinculin- of the ActA protein of Listeria monocytogenes (Shrm1-
1264ActA) was expressed in MLP-29 cells. In eukaryoticand b-catenin-positive AJs and adhere to fibronectin,
laminin, and collagen, suggesting that Shrm is not abso- cells, this sequence of ActA targets proteins to the mito-
chondrial outer membrane (Bubeck et al., 1997). Follow-lutely required for the formation of cell±cell or cell±ECM
adhesion structures (data not shown). ing transfection, cells were assayed for the subcellular
distribution of Shrm1-1264ActA and F-actin. This fusion
protein is efficiently expressed and, based on stainingShrm Can Direct the Subcellular Distribution
of Actin with Mito Tracker, targeted to the mitochondria (Figure
6G, data not shown). Costaining of cells with phalloidinTo address the possibility that Shrm could regulate as-
pects of cytoskeletal architecture, we assayed the con- reveals the recruitment of F-actin to mitochondria that
display Shrm1-1264ActA on their surface (Figure 6H). Itsequences of overexpressing ShrmL in mouse epithelial
cells (MLP-29 cells) that normally express low levels of should be noted that both Shrm1-1264ActA and ShrmL
do not colocalize exactly with F-actin (Figures 6C andShrm protein (data not shown). In these experiments, a
population of transfected cells exhibit abnormal actin 6I). In these experiments Shrm1-1264ActA causes the
aggregation of mitochondria, a result similar to that ob-structures that are partially coincident with the ectopi-
cally expressed protein (Figures 6A±6C). These struc- served for other actin-binding proteins targeted to mito-
chondria (Bubeck et al., 1997). Thus, it appears thattures appear to be actin aggregates that are surrounded
by ShrmL. To begin defining the domain structure of Shrm can function to direct the subcellular distribution
of F-actin in vivo.Shrm, various portions of Shrm were expressed in MLP-
29 cells and assayed for the ability to induce the aggre-
gation of F-actin. Actin aggregates are efficiently in- Shrm Is an F-Actin-Binding Protein
The above data suggest that Shrm may either induce theduced by amino acids 1±1264 (Figures 6D±6F), ShrmS,
and amino acids 286±1264, but not by amino acids 1±711 polymerization of new actin filaments or recruit existing
The Actin-Binding Protein Shrm in Neurulation
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Figure 5. Shrm Protein Expression and Sub-
cellular Localization
(A) Shrm was immunoprecipitated from wild-
type (11) and mutant (- -) E12.5 embryo ex-
tracts with anti-ShrmC (lanes 1 and 2) or pre-
immune sera (PI, lane 3) and detected by
Western blot using anti-ShrmC. Arrow de-
notes ShrmS and ShrmL protein.
(B±H) Primary neural tube cells from wild-type
embryos were labeled with anti-ShrmC alone
(B) or costained to detect Shrm and vinculin
([C] and [D], respectively), Shrm and b-cat-
enin ([E] and [F], respectively), or Shrm and
F-actin ([G] and [H], respectively). In (B)±(H),
arrows denote AJs, arrowheads indicate ac-
tin stress fibers, and the double arrowhead
highlights focal adhesions. Bar, 20 mm.
filaments to ectopic sites. To begin addressing these Conversely, a protein consisting of amino acids 1474±
1986 does not localize to the cytoskeleton and is cyto-possibilities, we mapped the region of Shrm that targets
it to F-actin by expressing fragments of Shrm in RAT1 solic (Figures 7G±7I). While amino acids 754±953 of
Shrm contain only a portion of ASD1, suggesting thisfibroblasts and assaying them for subcellular localiza-
tion. In these cells, ShrmL is efficiently targeted to actin domain is not required for actin binding, constructs that
contain all of ASD1 localize much more efficiently tostress fibers (Figures 7A±7C). Similarly, a portion of Shrm
consisting only of amino acids 754±953 is also targeted F-actin. It is known that the PDZ domain of Shrm does
not participate in actin localization, as ShrmS is targetedto actin stress fibers, albeit somewhat less efficiently
than ShrmL (Figure 7D-7F), suggesting the actin tar- to actin stress fibers and a fragment of Shrm containing
amino acids 1±711 is cytosolic (data not shown). Togeting sequence is located within these amino acids.
Figure 6. Shrm Recruits Actin to Ectopic
Sites
MLP-29 epithelial cells expressing ShrmL
(A±C), Shrm1±1264 (D±F), or Shrm1±1264
ActA (G±I) were labeled to detect Shrm (A, D,
and G,) and F-actin (B, E, and H); merge (C,
F, and I). Boxed regions in (A)±(C) and (G)±(I)
are enlarged (insets) to show ShrmL-induced
actin aggregates and recruitment of F-actin




Figure 7. Shrm Is an Actin-Binding Protein
(A±H) RAT1 fibroblasts expressing ShrmL (A±C),
Shrm754±953 (D±F), and Shrm1474±1986
(G±H) were labeled to detect Shrm (A, D, G)
and F-actin (B, E, H); merge (C, F, I). Arrow-
head shows colocalization. Bar, 20 mm. (J and
K) The interaction of Shrm with F-actin was
assayed in vitro using a cosedimentation
assay. Coomassie blue±stained gels of su-
pernatant (s) and pellet (p) fractions resulting
from sedimentation of solutions containing
F-actin plus either GST754±953 (lanes 3 and
4) or GST1474±1986 (lanes 1 and 2). Quantifi-
cation of the interaction between GST754±
953 and F-actin is shown in (K). Arrow,
GST754±953; arrowhead, GST1474±1986;
double arrowhead, actin.
determine whether Shrm localization is due to a direct dress this hypothesis, we assayed the subcellular distri-
bution of F-actin, b-catenin, and cortactin in the neuro-interaction with F-actin, we assayed a GST fusion pro-
tein containing amino acids 754±953 of Shrm for the epithelium of wild-type and mutant E9.75 embryos. In
wild-type embryos, b-catenin (Figure 8A) and F-actinability to bind F-actin in a cosedimentation experiment
(Figure 7J). In these experiments, GST754±953 is found (Figure 8A9) are colocalized (Figure 8A99) at the apical
surface of the neuroepithelium. In shrm mutant embryos,in the pellet, indicating it can directly bind F-actin (Figure
7, lane 4, arrow). Conversely, a GST fusion protein con- however, b-catenin and F-actin are poorly localized to
the apical surface and are more diffuse (Figures 8B-taining amino acids 1474±1986 of Shrm is found only in
the supernatant fraction and not in the F-actin pellet 8B99). Likewise, the apical localization of cortactin, a
cortical actin-binding protein, is also significantly re-(Figure 7J, lanes 1 and 2, arrowhead). No fusion protein
is precipitated in the absence of F-actin (data not duced in shrm mutant embryos (Figures 8D and 8F) as
compared with wild-type embryos (Figure 8C and 8E).shown). Initial analysis to determine the kinetics of this
interaction suggests the binding is saturable (Figure 7K). Costaining of these sections with DAPI to localize nuclei
did not reveal significant alterations in the overall apical±These results, in conjunction with those in the previous
section, suggest that Shrm is an F-actin-binding protein basal polarity of these cells, indicating that the observed
defects may affect only specific aspects of cellular orga-that can recruit existing actin filaments to ectopic sites
in the cell. nization.
To further determine whether the shrm phenotype is
due to an autonomous defect in the cytoskeletal polarityShrm as a Determinant of Cytoskeletal Polarity
The above results suggested a cytoskeletal basis for of the neuroepithelium, the cranial neural folds from
E8.75±E9.0 (12±15 somites) wild-type and mutant em-the NTDs exhibited by shrm mutant embryos. To ad-
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Figure 8. Abnormal Cytoskeletal Architecture in shrm Neural Tubes
(A and B) Frozen sections of wild-type (A) or shrm mutant (B) E9.75 embryos were assayed by fluorescent immunohistochemistry to detect
the localization of b-catenin (A and B) and F-actin (A9 and B9); merge (A99 and B99). Sections are from the region of the otic vesicle.
(C±F) Paraffin sections from E9.75 wild-type ([C] and [E], hindbrain and forebrain, respectively) or shrm mutant ([D] and [F], hindbrain and
forebrain, respectively) embryos were subjected to fluorescent immunohistochemistry to detect the distribution of cortactin.
(G and H) Subcellular distribution of actin in frozen sections of neuroepithelium isolated from wild-type (G) and mutant (H) embryos at the
12±15 somite stage of development and grown in collagen gels. In mutant samples, substantially less actin is found associated with the apical
surface. It should be noted that the cytoskeletal architecture in wild-type samples is slightly perturbed due to in vitro culture.
The double-headed arrow denotes the apical (a)±basal (b) polarity of the neuroepithelium (ne). Bar, 50 mm.
bryos were dissected away from the surface ectoderm Discussion
and surrounding mesenchyme and grown in collagen
gels. At this stage, mutant and wild-type embryos are This report describes the identification and character-
ization of a recessive lethal mouse mutation designatedphenotypically indistinguishable, and there were no ob-
vious differences between mutant and wild-type tissues shrm. The primary defect exhibited by shrm mutant
embryos is a pronounced failure in proper neural tubefollowing in vitro culture (data not shown). After 36 hr
of growth in vitro, the tissues were sectioned and stained morphogenesis. Several lines of evidence suggest that
shrm acts autonomously within the neuroepithelium towith phalloidin to determine the status of the actin cy-
toskeleton. In wild-type samples, actin is predominantly facilitate neurulation at the level of cellular cytoarchitec-
ture. First, shrm is strongly expressed in the rostrallocalized to the apical surface, indicating the overall
cytoskeletal polarity of the neural epithelium is main- neuroepithelium at the time of cranial neural tube closure
and is not expressed in the surrounding head mesen-tained in culture (Figure 8G). Due to atypical develop-
ment in culture, the apical localization of actin in the chyme. Importantly, this region of the neural tube is
affected in 100% of the shrm mutant embryos examined.wild-type cultures is slightly perturbed relative to that
observed in vivo. In mutant samples grown in culture, It is interesting that shrm expression within the neuro-
epithelium is quite dynamic, suggesting that the activityhowever, the subcellular distribution of F-actin is signifi-
cantly shifted away from the apical surface, similar to of Shrm may be required for only some aspects of neural
tube closure or in specific cell types within the neuro-what is seen in shrm mutant embryos in vivo (Figure
8H). Together, these data indicate that Shrm is involved epithelium. At E8.75±E9.25 shrm is expressed uniformly
in the neural tube rostral to the otic vesicle, while expres-in cytoskeletal architecture and its activity is a critical
intrinsic factor of neural tube closure. sion is restricted to the floor and roof plates of the neural
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tube caudal to the otic vesicle. The expression of shrm PDZ domain function, and the known mechanisms of
regulating cell shape and adhesion, it is tempting toin the roof plate is interesting, as this is the site where
fusion of the neural folds occurs and shrm mutant em- predict that Shrm is a multifaceted adaptor protein that
acts to determine cytoskeletal polarity or architecture.bryos display defects in this process. Second, in con-
trast to many of the existing mouse mutants that exhibit For example, the PDZ domain could bind the cyto-
plasmic tail of a membrane receptors while the actin-abnormal neurulation, the shrm mutation does not affect
patterning or growth in either the neuroepithelium or binding region directly interacts with F-actin. This type
of interaction could have at least two possible conse-the surrounding tissues. Third, we show that Shrm is a
cytoskeletal protein that can directly bind F-actin and quences. In one scenario, this interaction may serve to
define cytoarchitecture by anchoring actin stress fiberscontrol its subcellular distribution. Finally, in shrm mu-
tant embryos, cells comprising the neuroepithelium dis- to the plasma membrane. Conversely, Shrm could func-
tion to confine the subcellular distribution of membraneplay clear cytoskeletal defects.
receptors by concentrating them at regions where F-actin
is already highly localized. Interestingly, if Shrm actsShrm: A PDZ Domain±Containing Adaptor Protein?
as an adaptor protein, alternative inclusion of the PDZThe shrm gene encodes a PDZ domain protein, related
domain could significantly modulate its function. Finally,to Apx and APXL. While nothing is known about the
the fact that Shrm has a perfect binding site for EVH1function of APXL, Apx was shown to encode a protein
domains suggests that Shrm may play other roles inthat regulates aspects of sodium channel activity in a
modulating actin dynamics by recruiting cytoskeletalmanner that is controlled by the actin cytoskeleton
regulatory proteins such as VASP, Mena, and Evl (Gertler(Staub et al., 1992; Prat et al., 1996). By comparing the
et al., 1996) to specific sites in the cell.deduced amino acid sequences of Shrm, Apx, and
APXL, we predict that Shrm has a modular nature that
would allow it to function as an adaptor molecule or a Shrm, the Cytoskeleton, and Neural Tube Defects
Two critical steps in the process of neural tube closurecomponent of protein complexes. The high degree of
sequence conservation between Apx, APXL, and Shrm that appear sensitive to alterations in cytoskeletal integ-
rity are formation of the DLHPs and convergence ofin ASD1 and ASD2 suggests that these domains may
carry out important functions, perhaps as binding sur- the neural folds (Smith and Schoenwolf, 1997). These
aspects of neurulation are specific to the cranial neuralfaces or enzymes. This hypothesis is supported by the
fact that ASD1 appears to mediate, at least in part, the tube, a region that is severely affected in shrm mutant
embryos. DLHPs are formed, in part, by changes in cellinteraction of Shrm and F-actin. There are, however,
some interesting differences between Shrm, Apx, and shape, such that rectangular cells become wedge-
shaped, being wider at the basal side and narrowerAPXL. First, the reported sequence of Apx does not
contain the PDZ domain. Second, Shrm contains a po- at the apical side. It has also been proposed that a
contractile actin-myosin cytoskeleton underlying thetential PDZ domain±binding site at its C terminus that
is not conserved in Apx or APXL (Songyang et al., 1997). apical membrane of the neuroepithelium facilitates neu-
ral tube closer by functioning as a ªpurse stringº to pullResults from two-hybrid screening suggest this se-
quence is a functional ligand for PDZ domains, and the the neural fold toward the dorsal midline. It is intuitive
that these cell shape changes and contractile forcessignificance of these interactions is under investigation.
The presence of a PDZ domain in Shrm is compelling, require extensive, well-regulated mechanisms for mod-
ulating cell adhesion, cell movement, and cellular archi-as these domains mediate protein±protein interactions
that facilitate the localization of membrane proteins and tecture. However, recent work indicates that actin fila-
ments are required for maintaining the integrity of thethe assembly of signaling complexes (Ponting et al.,
1997). Extensive genetic, biochemical, and cell biologi- nonbending regions of the neural plate and not for DLHP
function (Ybot-Gonzalez and Copp, 1999), thus callingcal analysis has been performed in order to elucidate
the molecular nature of PDZ domains. Typically, PDZ into question the true role of the cytoskeleton in cranial
neurulation.domains accomplish this by binding the sequence Ser/
Thr-Xxx-Val/Iso/Leu located at the C terminus of target With the discovery that Shrm is a PDZ domain±
containing actin-binding protein that colocalizes withprotein (Ponting et al., 1997; Songyang et al., 1997). For
example, the InaD protein uses its five PDZ domains to F-actin and AJs, it is tempting to speculate that the NTDs
we observe are directly related to aberrant cytoskeletalassemble a signaling complex consisting of a trans-
membrane photoreceptor, PKC, and PLC (Tsunoda et architecture, cell polarity, or cell adhesion. Our results
support this hypothesis, since the integrity of the apicalal., 1997; Xu et al., 1998b). Similarly, experiments em-
ploying biochemistry and C. elegans genetics showed cytoskeleton is perturbed in the neuroepithelium of shrm
mutant embryos. It is currently unclear where Shrm sitsthat the PDZ domain proteins Lin-2, Lin-7, and Lin-10
form a complex that regulates the basolateral localiza- in the pathway leading from cadherin-mediated adhe-
sion to cytoskeletal organization. It is possible that Shrmtion of the Let-23 receptor tyrosine kinase in polarized
epithelial cells (Kaech et al., 1998). acts at the level of AJ formation. This idea is partially
supported by the observation that b-catenin is some-Shrm is a cytoskeletal protein that is capable of bind-
ing F-actin in vitro and directing its subcellular distribu- what mislocalized in shrm mutant embryos. However,
because Shrm-deficient primary neural tube cells formtion in vivo. These observations are interesting in light
of fact that the shrm phenotype appears to result from vinculin- and b-catenin-positive AJs in vitro, we cannot
rule out the possibility that the observed perturbationa physical defect in neural tube morphogenesis. Based
on the modular nature of Shrm, the above models of in b-catenin localization is secondary to a cytoskeletal
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detected using FITC-conjugated donkey anti-chicken (Jackson Im-defect. Alternatively, it is possible that Shrm binds actin
munoresearch), Alexa 488-conjugated goat anti-chicken (Molecularand helps to localize or stabilize the cortical cytoskele-
Probes), TR- or FITC-conjugated donkey anti-mouse (1:400, Jack-ton. Both of these possibilities are supported by the
son Immunoresearch), and TR-conjugated donkey anti-rabbit
mislocalization of F-actin and cortactin in shrm mutants. (1:400, Jackson Immunoresearch). F-actin was detected with
Since the shrm mutation affects specific processes TRITC-conjugated phalloidin (Sigma). Mitochondria were detected
using Mito Tracker Green FM (Molecular Probes) per the manufac-of neural tube formation, this should be a useful mutation
turer's recommendations. Cells and sections were fixed and stainedfor studying the role of the cytoskeleton in neural tube
as described previously (Gertler et al., 1996; Koleske et al., 1998).formation. Furthermore, because the shrm/apx family of
Images were captured using either a Zeiss Axioplan, Deltavisiongenes are different from other known components and
deconvolution imaging microscope, or a Leica TCS confocal micro-
regulators of the cytoskeleton, these proteins may carry scope and processed using Adobe Photoshop.
out unique functions or be involved in new molecular
pathways not previously implicated in cellular architec- Isolation and Culture of Neural Tubes
ture or embryonic morphogenesis. Embryos were isolated and treated with a mixture of Dispase/Colla-
genase (Boehringer Mannheim) at 1 mg/ml in PBS for 15 min at 48C
followed by 7 min at 378C. Neural tubes were broken up into smallerExperimental Procedures
pieces and plated onto fibronectin-coated coverslips. Neural tubes
were cultured for 3±4 days in DMEM/10% fetal bovine serum (FBS).Gene Trap Vectors and ES Cells
Alternatively, neuroepithelial cells were isolated and grown inA gene trap cassette, SAbgalCrepA, containing an adenovirus splice
DMEM/10% FBS supplemented with 20 ng/ml FGF-2 (Boehringeracceptor (Friedrich and Soriano, 1991), a bifunctional gene fusion
Mannheim) and 8 mg/ml heparin as described (Kilpatrick and Bart-between b-galactosidase (b-gal) and the Cre recombinase, and the
lett, 1993). After 24 hr, cells were replated and grown in the presenceMC1 polyadenylation (pA) sequence (Thomas and Capecchi, 1987)
of FGF-2. Colonies of cells exhibiting an epithelial morphology werewas generated. This cassette was cloned into pGen2 (Soriano et
isolated, pooled, expanded, and tested by either X-gal staining oral., 1991) to make the retroviral vector ROSA-bgalCre (ROSA, reverse
immunofluorescence staining to determine whether they retainedorientation splice acceptor). ROSA-bgalCre was introduced into the
shrm expression. These cells were then assayed for cytoskeletalpackaging line GP1E86 as described (Soriano et al., 1991). Virus
architecture, formation of adhesion structures, and adhesion to ECMwas harvested and used to infect AK7 ES cells harboring a reporter
components.that selects for Cre activity. ES cells harboring gene trap insertions
For in vitro culture of neural tissue, neuroepithelium was dissectedwere used to generate chimeric mice by blastocyst injection, and
away from the majority of the surface ectoderm and mesenchymegermline transmission was achieved by mating male chimeric mice
following dispase/collagenase digestion for 10 min at 48C followedto wild-type females.
by 4 min at 378C. Isolated neuroepithelium was imbedded in collagen
gel (Collaborative Biomedical) and grown in Hams F12 supple-Cloning of shrm
mented with N2 supplement (GIBCO±BRL), glutamine, and antibiot-59-RACE was carried out using RNA from mutant embryos as de-
ics for 36 hr at 378C.scribed (Frohman et al., 1988). The b-gal gene-specific primers
(GSP) used were as follows: GSP1, 59-CCGTGCATCTGCCAGT
HistologyTTGAGGGGA-39; GSP2, 59-CGACGACAGTATCGGCCTCA-39; and
For X-gal staining, embryos were fixed and stained as describedGSP3, 59-CAGCTTTCCGGCACCGCTTC-39. The gene nonspecific
(Friedrich and Soriano, 1991). Embryos used for histology were fixedprimers used were as follows: QT, 59-CCAGTGAGCAGAGTGAC
in 4% PFA at 48C, dehydrated in ethanol, cleared in Histoclear (Na-GAGGACTCGAGCT CAAGC(T)17-39; Q0, 59-CCAGTGAGCAGAGT
tional Diagnostics), and embedded in paraffin. Five-micrometer sec-GACG-39; and Q1, 59-GAGGACTCGAGCTCAAGC-39. A 240±base
tions were mounted on TESPA-coated slides, dewaxed, hydrated,pair (bp) fragment was isolated and used to screen a mouse brain
and stained with Harris hematoxylin and eosin-Y (H&E). For immuno-cDNA library (Stratagene, La Jolla, CA). One clone (l1) was isolated
fluorescence, embryos were fixed in 4% PFA at 48C, dehydrated inand sequenced. l1 contained 120 bp of sequence identical to the
ethanol, cleared in xylene, and embedded in paraffin. Four-microme-59-RACE product and 380 bp of unique sequence and was used to
ter sections were dewaxed and hydrated in PBS prior to addition ofscreen the brain library and an ES cell cDNA library to obtain further
antibody. Ten-micrometer frozen sections of embryos and collagen59 and 39 sequence. Mice harboring the mutation are genotyped by
gels were prepared as described (Koleske et al., 1998). ScanningSouthern blot using the 59RACE product, which identifies a restric-
electron microscopy was carried out following a previously de-tion fragment polymorphism caused by the insertion (data not
scribed technique (Stanisstreet, 1990).shown). MacVector and ClustalW were used for sequence analysis
Whole-mount RNA in situ hybridization and immunohistochemis-and alignments.
try was performed as described (Hogan et al., 1994) using the follow-
ing probes: twist 39 UTR (R. Behringer), wnt3A (H. Roelink), 800 bpAntibodies, Western Blotting, and Immunofluorescence
fragment from krox20 (W. Shawlot), a 2.5 kb fragment of rat sonicChicken anti-Shrm antibodies were generated against GST fusion
hedgehog (H. Roelink), the 39UTR of PDGFa receptor (M. Tallquistproteins containing amino acids 1±250 (ShrmN) or amino acids
et al., unpublished data), rabbit anti-Mox1 serum (C. Wright and1474±1986 (ShrmC) by Aves Labs. To immunoprecipitate Shrm, af-
A. Candia), and anti-neurofilament mAb 2H3 (T. Jessell). TUNELfinity-purified anti-ShrmC (1:100) was added to 500 mg total cell
analysis, to detect apoptosis, and BrdU incorporation, to detectlysate in 1 ml of RIPA lysis buffer derived from mutant or wild-type
proliferating cells, were performed as described (Soriano, 1997).embryos and incubated at 48C for 1 hr. Shrm immune complexes
were collected with rabbit anti-chicken IgY (Jackson Immunore-
search) bound to protein A-Sepharose 4B (Pharmacia) and washed Expression of Shrm Variants
The following Shrm constructs were generated and used for expres-three times with RIPA and twice with TBS at 48C. Shrm was detected
by Western blot with anti-ShrmC (1:500 dilution), HRP-conjugated sion in eukaryotic cells or bacteria. A cDNA encoding ShrmL (1±1986)
was assembled and cloned into the expression vector pCS2. Shrm1±goat anti-chicken (1:2500, Jackson Immunoresearch), and ECL re-
agent (Amersham). 1264 was generated by cloning DNA encoding amino acids 1±1264
into pCS2. Shrm1±1264actA was generated by cloning cDNA encod-Indirect immunofluorescence on cells and sections was per-
formed using affinity-purified anti-ShrmC (1:25 dilution), anti-ShrmN ing amino acids 1±1264 into the vector pSPL61±2 (from J. Wehland).
For Shrm754±953 and Shrm1474±1986, cDNA encoding amino acids(1:15), vinculin-specific mAb hVin-1 (Sigma), cortactin-specific mAb
4F11 (10 mg/ml, from T. Parsons), rabbit anti-b-catenin (1:400, from 754±953 and 1474±1986 were cloned into pCS3mt (a derivative of
pCS2 containing a Myc epitope tag) or pGEX3X. For transfectionJ. Brown and R. Moon), and anti-Myc mAb 9E10 (from R. Scheaff
and J. Roberts). Nuclei were stained with DAPI (1:10,000 in PBS, assays, 2 3 105 MLP-29 epithelial cells (from E. Medico) or RAT1
fibroblasts were plated on gelatin-coated coverslips, grown overSigma) for 5 min at room temperature. Primary antibodies were
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night in DMEM/10% calf serum, and transfected with 1 mg plasmid for MafB/Kreisler segmental expression in the hindbrain. Develop-
ment 125, 1173±1181.DNA using Lipofectamine (GIBCO±BRL) per the manufacturer's rec-
ommendations. Gumbiner, B.M. (1996). Cell adhesion: the molecular basis of tissue
architecture and morphogenesis. Cell 84, 345±357.
Actin Cosedimentation Assay Gumbiner, B.M., and McCrea, P.D. (1993). Catenins as mediators
GST754±953 and GST1474±1986 fusion proteins were expressed of the cytoplasmic functions of cadherins. J. Cell Sci. Suppl. 17,
and purified from E. coli. Purified, eluted fusion proteins were pre- 155±158.
cleared by high-speed centrifugation, added to F-actin (2 mM final
Haegel, H., Larue, L., Ohsugi, M., Fedorov, L., Herrenknecht, K., and
concentration, Cytoskeleton, Inc), and incubated for 1 hr at room
Kemler, R. (1995). Lack of beta-catenin affects mouse development
temperature. F-actin was pelleted by centrifugation in a Beckman
at gastrulation. Development 121, 3529±3537.
Airfuge for 1 hr at 48C, and equal amounts of the pellet and superna-
Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994). Manip-tant fractions were resolved by SDS±PAGE and stained with Coo-
ulating the Mouse Embryo: A Laboratory Manual (Cold Spring Har-massie blue. Stained gels were scanned and quantified using NIH
bor, NY: Cold Spring Harbor Laboratory).image software.
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